As we urged, the Nevada Supreme Court holds that ordinary people like Stephen can sue for damages when government officials go over the line and violate the most basic guarantees in the state constitution.
Even without those side effects, having no appetite is a horrible feeling. Not taking in enough calorieswhether its from a medication or notis highly problematic for athletes, Emily Smith, M.D., an endocrinologist and obesity medicine specialist in Boston tells Runners World
Particularly noteworthy is that in patients with both type 2 diabetes and MASLD, after 24 weeks of treatment with a 10 mg dose of efinopegdutide, liver fat content reduced by 72.7%, a result that is superior to the 42.3% reduction achieved with a 1 mg dose of semaglutide, despite a similar overall weight loss being observed with the two interventions
23 July 2026 FDA committee update: what changed for BPC-157
Use of GLP-1 receptor agonist and risk of osteoporosis among patients with type 2 diabetes
